Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$102.66
+2.7%
$124.64
$96.43
$155.35
$29.29B1.191.85 million shs1.94 million shs
Illumina, Inc. stock logo
ILMN
Illumina
$74.76
+4.9%
$89.57
$68.70
$156.66
$11.80B1.382.26 million shs2.12 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
-6.78%-9.00%-17.65%-27.45%-30.79%
Illumina, Inc. stock logo
ILMN
Illumina
-6.61%-6.75%-15.69%-47.87%-45.67%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
4.4695 of 5 stars
3.25.01.73.63.40.81.3
Illumina, Inc. stock logo
ILMN
Illumina
4.6292 of 5 stars
4.25.00.04.22.21.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.46
Hold$146.2542.46% Upside
Illumina, Inc. stock logo
ILMN
Illumina
2.48
Hold$138.7085.52% Upside

Current Analyst Ratings Breakdown

Latest A and ILMN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$135.00
4/10/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$138.00 ➝ $115.00
4/10/2025
Illumina, Inc. stock logo
ILMN
Illumina
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$100.00 ➝ $77.00
4/8/2025
Illumina, Inc. stock logo
ILMN
Illumina
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $112.00
4/7/2025
Illumina, Inc. stock logo
ILMN
Illumina
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$90.00 ➝ $85.00
3/12/2025
Illumina, Inc. stock logo
ILMN
Illumina
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$247.00 ➝ $128.00
3/11/2025
Illumina, Inc. stock logo
ILMN
Illumina
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderweight ➝ Underweight
3/11/2025
Illumina, Inc. stock logo
ILMN
Illumina
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$156.00 ➝ $156.00
3/11/2025
Illumina, Inc. stock logo
ILMN
Illumina
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$135.00 ➝ $115.00
3/5/2025
Illumina, Inc. stock logo
ILMN
Illumina
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$127.00 ➝ $90.00
3/4/2025
Illumina, Inc. stock logo
ILMN
Illumina
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$130.00 ➝ $90.00
(Data available from 4/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.51B4.50$5.99 per share17.13$20.53 per share5.00
Illumina, Inc. stock logo
ILMN
Illumina
$4.37B2.71$3.61 per share20.72$14.98 per share4.99
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.29B$4.3523.6216.883.0019.27%25.56%13.47%5/27/2025 (Estimated)
Illumina, Inc. stock logo
ILMN
Illumina
-$1.22B-$7.68N/A14.491.60-27.95%13.37%5.49%5/1/2025 (Estimated)

Latest A and ILMN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
Illumina, Inc. stock logo
ILMN
Illumina
$0.94N/AN/AN/A$1.03 billionN/A
2/26/2025Q1 2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.27$1.31+$0.04$1.11$1.67 billion$1.68 billion
2/6/2025Q4 2024
Illumina, Inc. stock logo
ILMN
Illumina
$0.92$0.86-$0.06$1.17$1.08 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$0.990.96%+6.47%22.76%N/A
Illumina, Inc. stock logo
ILMN
Illumina
N/AN/AN/AN/AN/A

Latest A and ILMN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/19/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.24800.72%4/1/20254/1/20254/23/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.56
2.20
1.66
Illumina, Inc. stock logo
ILMN
Illumina
0.63
1.77
1.42

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Illumina, Inc. stock logo
ILMN
Illumina
89.42%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Illumina, Inc. stock logo
ILMN
Illumina
0.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
17,900285.10 millionN/AOptionable
Illumina, Inc. stock logo
ILMN
Illumina
11,500158.40 million158.13 millionOptionable

Recent News About These Companies

Illumina price target lowered to $77 from $100 at Barclays
Illumina (NASDAQ:ILMN) Sets New 52-Week Low After Analyst Downgrade
Citigroup Lowers Illumina (NASDAQ:ILMN) Price Target to $85.00

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agilent Technologies stock logo

Agilent Technologies NYSE:A

$102.70 +2.75 (+2.75%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Illumina stock logo

Illumina NASDAQ:ILMN

$74.73 +3.47 (+4.87%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.